Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 8Pancreatic Neoplasms 7Neoplasms 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Colorectal Neoplasms 3Stomatitis 2Skin Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia 2Inflammation 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Myofibroma 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1

Interventions

Surveys and Questionnaires 5Pemetrexed 3Paclitaxel 3Gemcitabine 3Docetaxel 3Brachytherapy 3pembrolizumab 2Topotecan 2Saline Solution 2Radiotherapy 2Radiation 2FANG vaccine 2Everolimus 2Doxorubicin 2Cisplatin 2Carboplatin 2CP protocol 2temsirolimus 1selinexor 1osimertinib 1niraparib 1fosaprepitant 1ferumoxtran-10 1ferrous fumarate 1durvalumab 1cobimetinib 1atezolizumab 1alovudine 1Vitamin D 1Uterine Artery Embolization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Neoplasms × Ascorbic Acid × Clear all
NCT00284427 2016-02-10

Safety of Antioxidants During GYN Cancer Care

University of Kansas Medical Center

Phase 2 Completed
25 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡